Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-01-10 @ 12:26 AM
Study NCT ID:
NCT06249620
Status:
COMPLETED
Last Update Posted:
2024-02-08
First Post:
2023-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Supplementation With AM3, Hesperidin and Spermidine Supplementation on Immunity Response and Biological Age.
Sponsor:
Industrial Farmacéutica Cantabria, S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
P21110b
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None